Mashal Robert

SEC Form 4 insider trading activity

Mashal Robert has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.

On the most recent filing, Mashal Robert is listed as Director at Nuvation Bio Inc. Inside the rolling window, Mashal Robert reported 1 open-market purchase totaling $118K in NUVB and no open-market sales.

Companies traded

Other insiders at NUVB

Insider Buying

$118K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NUVBPurchase$118KJun 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mashal Robert made?

Mashal Robert has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Mashal Robert trade?

Mashal Robert has filed SEC Form 4 disclosures for 1 company, including NUVB.

When was Mashal Robert's most recent SEC Form 4 filing?

Mashal Robert's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.

What is Mashal Robert's total buy and sell value in the current window?

Inside the rolling retention window, Mashal Robert bought $118K and sold $0 based on SEC Form 4 filings.

What was Mashal Robert's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 25,000 NUVB shares on 2026-06-09, worth $118K, per SEC Form 4 filings.